
Last updated: 2026-09-16 09:46:20. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
AnaptysBio, Inc. (ANABV) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at --, with a market capitalisation of -- and a P/E ratio of --. Over the past 52 weeks, its price has ranged from -- to --. This page covers its latest market performance, valuation, price trends and company information.
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- |
AnaptysBio, Inc. (ANABV) is trading at $-- in pre-market trading as of --, -- from the previous close of $--
Pre-market trading shows how investors are pricing ANABV before the regular session opens. The current pre-market price is -- the previous close, indicating -- early trading sentiment.
Over the past seven days, AnaptysBio, Inc. (ANABV) moved from $45.52 to $43.80, representing a decline of 3.78% ($1.72).
The stock traded between $41.99 and $49.76 during the period. The latest price is near the lower end of the 7-day range, indicating moderate downward.
The average daily volume was 3.01 thousand shares, -- versus the previous seven-day period, indicating -- trading activity.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Exchange | NASDAQ |
Eligible investors can buy real shares of AnaptysBio, Inc. (ANABV) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.